Method of shaping structures with an overcoat layer including female urinary catheter

Information

  • Patent Grant
  • 6626888
  • Patent Number
    6,626,888
  • Date Filed
    Tuesday, September 26, 1995
    29 years ago
  • Date Issued
    Tuesday, September 30, 2003
    21 years ago
Abstract
A method shaping polymeric structures by coating a support structure with a bond-preventing agent to attain a particular shape and subsequently coating the shaped structure of the bond-preventing agent with a polymeric bonding composition is provided. Such shaped polymeric structures can have one or more cavities which can be fluid-filled or gel-filled. Also provided is a hand-actuating retention female urinary catheter having an inner tube and an outer overcoat layer encircling the tube with an elastomeric collar with a shroud. A cavity containing a fluid is interposed between the tube and the overcoat layer. The cavity includes a balloon portion and a reservoir portion. The shroud encircles the reservoir section to inhibit the ballooning of the reservoir section when the reservoir section is squeezed to force fluid from the reservoir portion to the balloon portion through the sleeve portion of the cavity. The overcoat layer and the collar with a shroud are made of soft resilient material.
Description




FIELD OF THE INVENTION




The present invention relates to methods of making shaped structures with an overcoat layer. The present invention also relates to making polymeric structures such as cannulas and catheters. In addition, the present invention also relates to urinary catheters and most particularly to female urinary catheters.




BACKGROUND OF THE INVENTION




Many structures, for example, hoses, condoms, gloves, cannulas, catheters, and the like, are made of a polymeric material (e.g., latex, silicone). Such polymeric structures may have various shapes, e.g., sections with different diameters, contours, etc. In addition, various cavities might be present in the structures, some of which might contain fluids of various types. A traditional way to form such structures is by adhesively affixing parts together so that the outer coat can attain the desired shape. However, these traditional methods do not lend themselves to mass production and are labor intensive. Some shapes are extremely difficult if not impossible to make by traditional adhesive methods. likewise, traditional methods of making shaped structures of nonpolymeric substances, such as inorganic materials, with cavities therein sometimes have similar difficulties.




An example of a shaped polymeric structure is a catheter. Most catheters are cannulas or tube like devices which are inserted into a portion of a person's body in order to transport fluids, such as liquids, gases, and sometimes semisolid material, in or out of that particular portion of the body. For instances, urinary catheters are used to transport urine collected in the bladder out of the body via the urinary tract. Other types of catheters such as gastronomy devices, transport fluids into and out of various segments of the gastrointestinal system, primarily the stomach.




In order to provide a means of retaining the catheter within the body, inflatable bag catheters were introduced many years ago. Subsequently, Foley (U.S. Pat. No. 3,409,016) taught an elongated catheter having a secondary lumen for inflating a retention balloon at a distal end of the catheter once the distal end is positioned within the body. Generally, the “distal end” is the end of the catheter that is first introduced into the body when the catheter is being positioned within the body and the “proximal end” is the end opposite the distal end. Such catheters are now generally referred to as “Foley” catheters out of respect for the contribution made by Dr. Foley. Because of the variation in needs of patients, improvements on Dr. Foley's contribution to the catheter art are continually being made. These improvements sometimes result in cannulas or catheters that have shapes quite different from that of the device originally designed by Dr. Foley.




Traditionally, Foley catheters are made by a process which includes slipping a band of cured rubber over a double lumen latex rubber tubing and affixing the band on the double lumen tubing by dipping the band and the tubing in a suspension of latex to form an outer layer. The cost of manufacturing traditional Foley catheters has been influenced by the need to use a significant amount of hand labor to make the devices, especially the silicone rubber Foley catheters. Moreover, in many cases where a polymeric structure such as a catheter is to have a cavity filled with fluid, traditional manufacturing methods can not be used. It will be appreciated that using such traditional methods to make catheters that have a variety of shapes and sizes of cavities between the tubing and the outer layer would add significantly to the cost of production and pose limitations on the variety of catheters that can be made. Reducing the amount of hand labor in the manufacture of such devices may reduce the cost of such devices so as to provide a more affordable product to the consumer and to render such a product more competitive in the market place.




The same problem of high labor cost and limitation of the variety of shapes is similarly encountered in the manufacture of other shaped structures such as gastronomy devices, condom, and hoses. The present invention provides a method of making polymeric structures which offers substantial advantages over traditional manufacturing methods. In addition, the present invention provides a simple, easily applied, comfortable disposable catheter for incontinent females.




SUMMARY OF THE INVENTION




Method of Making Polymeric Structures




The present invention relates to making a shaped structure by coating at least a portion of a shaped structure of a bond-preventing agent with a liquid composition, e.g. a polymeric bonding composition such as one that contains uncured silicone rubber, to attain an overcoat layer of a desired shape. The shaped structure of a bond-preventing agent can be formed by coating over an outer surface of a support structure, for example, a mandrel or a tube, to form a residual coating of a particular shape.




One embodiment of the present invention relates to dipping a mandrel in a liquid composition, such as polymeric composition to form an inner piece (or structure) over a surface of a mandrel, applying and shaping a residual coating of a bond-preventing agent over the outer surface of the inner piece, and coating at least a portion of the structure resulting from the previous steps with a liquid composition to form a shaped structure having an overcoat on an inner piece.




Another embodiment of the present invention relates to a method of making a polymeric structure in accordance with one of the above methods wherein a fluid-filled cavity is formed between an inner polymeric layer and an outer polymeric layer.




Yet another embodiment of the present invention relates to a method of making a polymeric structure in accordance with one of the above methods wherein an outer polymeric layer only partially encapsulates an inner polymeric layer such that only one end of the outer polymeric layer is attached to the polymeric structure. This method might be utilized to form a polymeric structure having an umbrella-like structure.




It will be appreciated that shaped structures of varying shapes can be formed by the present invention. The shaped structures formed by the present invention might be hollow, liquid-filled, gel-filled, etc. and/or might include a solid piece as well as combinations thereof.




The coating of the bond-preventing agent can have a varying thickness on different portions of an outer surface of the inner piece. The coating of the bond-preventing agent remaining on the inner piece before the coating of the liquid composition is herein referred to as the “residual coating.” The shape of the overcoat layer results from the varying thicknesses of the residual coating of the bond-preventing agent.




In one embodiment, the forming of residual coating of varying shapes can be done by coating portions of an outer surface of the inner piece with a bond-preventing agent in a plurality of dipping steps by immersing the inner piece into the bond-preventing agent to a desired depth for a desired length of time and subsequently removing the inner piece from the bond-preventing agent. The desired depth and the desired length of time for each of the plurality of dipping steps is selected so that a residual coating of bond-preventing agent of desired thickness and shape remains on portions of the inner piece following the plurality of dipping steps. The residual coating has a specific shape as a result of the variation between the depth of any two of the plurality of dipping steps, the number of dipping steps, the length of time between any two of the plurality of dipping steps, and the varying speeds of withdrawal from the liquids in dip tanks. By appropriate coating and stripping sequence, the bond-preventing agent can be sculpted to result in desired, symmetrical shapes much as the shapes achievable using a lathe. The sculpted residual coating can have varying thickness, curves, and angles, and therefore a specific, desired shape. By subsequently coating the residual coating of bond-preventing agent, which coats the inner piece, with a polymeric bonding composition, a shaped overcoat layer is formed wherein the shape of the overcoat layer results from the varying shapes of the residual coating. Also, other shaped structures, such as a bullet-shaped, molded, solid polymeric tip can be added to the inner piece before the formation of the overcoat layer to attain a desirable shape for a particular part of the shaped structure with the polymeric overcoat. As used herein, two structures of similar shapes but having unequal ratios of dimensions in the two structures are considered to have different shapes. For example, annular cylinders with the same inside diameter and length but different outside diameters are not considered to have the same shape. As used herein, the residual coating is still considered “a residual coating” even if it is not continuous over two or more portions of the inner piece as long as the coating is not radially separated into layers by a different intervening substance.




In one embodiment, the step of coating the inner piece with the bond-preventing agent can include a step of stripping the inner piece by immersing the inner piece in a stripping fluid to a desired depth for a desired length of time following any of the plurality of dipping steps in order to remove at least a portion of the bond-preventing agent from the outer surface of the inner piece. After the stripping step, the inner piece can be dipped into the bond-preventing agent again to form another coat of the bond-preventing agent on a selected portion of the inner piece if desired. The portion of the inner piece that has been stripped can be dipped in a bond-preventing agent to form a coating. If desired, to form a particular shape, both the stripped portion of the inner piece and a portion of the bond-preventing agent coating that remains on the inner piece can be dipped into the bond-preventing agent. The thickness of the bond-preventing agent coating can be increased by repeating the dipping and removal steps.




In one embodiment the inner piece might be a simple cylindrical mandrel. Such a mandrel can be used for making, for example, a polymeric hose or tube. In another embodiment, the inner piece can be a polymeric tube. Such a polymeric tube can either be purchased or formed by a process that comprises dipping a mandrel in a polymeric bonding composition. Such a polymeric tube typically can have a closed tip at one end.




In an alternate embodiment, a method of mass producing polymeric structures is provided. This method comprises providing a plurality of mandrels, each mandrel having the aforementioned elements; coating portions of an outer surface of the mandrel with a bond-preventing agent in a plurality of dipping steps by immersing the mandrel into the bond-preventing agent to a desired depth for a desired length of time and removing therefrom, stripping portions of the bond-preventing agent by dipping in a stripping agent, and alternately dipping and stripping to achieve the desired shape, and then coating the mandrel, now at least partially coated with the bond-preventing agent, with a polymeric bonding composition to form a shaped overcoat layer.




The present invention enables the production of structures, such as polymeric structures, with a great reduction of hand labor, which not only is costly, but also contribute to inconsistent results. The present invention can be adapted to produce structures of a wide variety of sizes and shapes by varying the thickness of the residual coating of the bond-preventing agent. The variation of the thickness of the residual coating of the bond-preventing agent can be designed to result in a structure with an overcoat of a specific shape. Because of the variation of need for different types of structures, e.g., simple Foley balloon catheters for placement in the urinary tract, balloon catheters with cavities containing bactericidal agents, catheters with cylindrical sleeve with a lubricant, and the like, a variety of shapes are needed for such structures.




The present invention also provides the advantage of obviating the need to machine a solid (such as metallic) mandrel of a specific shape for making a structure with overcoat of that specific shape. Moreover, often such mandrels cannot be used to make overcoat layers of complex shapes. For example, once a polymeric overcoat layer is formed on a mandrel with a shape as that of the inner tube and the coating of bond-preventing agent shown in

FIG. 11A

, it is very difficult to remove the overcoat layer from the mandrel. Although injection molding using very expensive cavity molds may be used to make structures with overcoat layers, the resulting overcoat layer has “part lines” where the mold is opened to allow removal of the molded structure. Such shortcomings can be overcome by using the method of the present invention.




In the making of polymeric structures using the method of the present invention, the outside dimensions (e.g. diameter) can be made with more consistency than in similar products made by traditional manufacturing methods, such as affixing balloon portions to the outer surface of a tube by hand. The method of the present invention makes possible the highly automated process of fabricating polymeric structures with shaped gel-filled, liquid filled cavities, especially those with a soft, outer, elastomeric layer that can conform to the contour of a surface in contact therewith.




Female Catheter




The present invention further relates to a female catheter having an inner tube and an outer layer encircling the tube. In an embodiment of a female catheter of the present invention, a cavity is interposed between the tube and overcoat layer. A fluid is contained in the cavity. The cavity is enlarged at two spaced apart locations along the inner tube so as to form a balloon portion and a reservoir portion connected by a sleeve section. The sleeve portion is in fluid communication with the balloon and reservoir portions such that fluid is capable of flowing between these portions whereby the size of the balloon and reservoir portions can vary depending on the amount of fluid in each of the portions. The reservoir portion at a proximal end of the catheter is normally in an enlarged state although it is readily compressible into a compressed state. The overcoat has reservoir, sleeve, and balloon sections corresponding to the respective portions of the cavity.




In one embodiment of the invention, a collar encircles the sleeve section of the overcoat to restrict fluid flow between the various portions of the cavity through the sleeve portion and a shroud encircles the reservoir section of the overcoat to limit lateral ballooning thereof when the reservoir section is compressed by forces not completely enveloping the reservoir section.




In another embodiment of the invention, a female catheter as described above further includes a removable stiff plastic stylet inserted into the inner tube to facilitate insertion of the catheter.




The present invention provides a simple, comfortable, disposable female catheter which can be manually inserted by incontinent females and is hand-actuated to achieve retention in a body passageway.




In using one embodiment of the present invention, a distal end of the catheter is inserted into the urethral tract by exerting force on the stylet. Upon emergence into the bladder of the first balloon section at the distal end of the catheter, the fluid in the reservoir portion of the cavity can be forced through the sleeve portion into the balloon portion by compressing the reservoir section of the overcoat layer to inflate the balloon section, thus retaining the catheter in the body passageway. The sleeve section of the catheter can be made to conform to the urethral tract walls providing a leak proof fit. It will be appreciated, that the catheter can allow the inner drain tube to twist and move within the soft outer layer. An elastomeric shroud encircles the reservoir section of the overcoat to limit the lateral ballooning thereof. An elastomeric collar restricts the sleeve section to prevents fluid from being forced back from the balloon portion to the reservoir portion of the cavity during normal activities of the user.




This catheter has the advantage that a limited amount of fluid is confined in the cavity, and therefore the balloon cannot be overinflated. The utilization of a stylet facilitates the insertion of the catheter. The length of the catheter can be designed such that as the reservoir section of the catheter is proximate the outside entrance of the urethra, the balloon section is disposed in the bladder proximate the entrance to the urethra effective to prevent fluid communication between the urethra and the bladder. The catheter can be made with soft material. Because the overcoat layer of the catheter gently conforms to the urethral wall, irritation to the body tissue is greatly reduced, thus lowering the risk of infection. Further, when the catheter is to be withdrawn, the restriction on the sleeve section can be easily removed by pulling the shroud and the collar from the catheter. Therefore, the retention catheter can be easily inserted, positioned, and withdrawn by the patient without the aid of a health professional.




In one embodiment, the fluid in the catheter is mineral oil. The mineral oil migrates to an outer surface of a silicone rubber outer layer to provide a lubricated, low friction surface.




The present invention, its advantages and other objects obtained by its use are also illustrated by the drawings, and the accompanying descriptive material, in which the preferred embodiments of the present invention are described.











BRIEF DESCRIPTION OF THE DRAWINGS




In the drawings, in which like and primed reference numerals indicate corresponding parts throughout the several views,





FIG. 1

is a transverse schematic view of a retention catheter made in accordance with the present invention in cross-section;





FIG. 2

is a transverse schematic view of a tube in partial cross-section which can be used to make the retention catheter shown in

FIG. 1

;





FIG. 3

is a side view of a mandrel for making an embodiment of the retention catheter of the present invention;





FIG. 4

is a cross-sectional view of the mandrel shown in

FIG. 3

when secured on a moveable pallet, and following the addition of a coating of a polymeric bonding composition to the mandrel;





FIG. 5

is a cross-sectional view similar to that shown in

FIG. 4

but after the addition of a coating of a removable bond-preventing agent to a portion of the outer surface of the tube;





FIG. 6

is a view similar to that shown in

FIG. 5

, but after the addition of an additional thickness of the removable bond-preventing agent to the outer surface of the tube;





FIG. 7

is a transverse schematic view of the tube shown in

FIGS. 4-6

, but showing only the removable bond-preventing agent in cross-section and only after a portion thereof has been removed from the outer surface of the tube;





FIG. 8

is a transverse schematic view similar to that shown in

FIG. 7

, but after an additional coating of removable bond-preventing agent has been added to the outer surface of the tube;





FIG. 9

is a transverse schematic view similar to that shown in

FIG. 8

, but after a further thickness of removable bond-preventing agent is added to the outer surface of the tube;





FIG. 10

is a transverse schematic view similar to that shown in

FIG. 9

, but after a portion of the removable bond-preventing agent on the outer surface of the tube is removed;





FIG. 11A

is a transverse schematic view similar to that shown in

FIG. 10

, but showing an overcoat layer on the removable bond-preventing agent in cross-section on the outer surface of the tube;





FIG. 11B

is a view similar to

FIG. 11A

except that the bond-preventing agent has been generally replaced by mineral oil;





FIG. 12

is a schematic illustration of apparatus used to automate the production of retention catheters in accordance with the present invention similar to that shown in

FIG. 1

;





FIGS. 13A

,


13


B and


13


C are flow charts disclosing steps of methods of manufacturing retention catheters in accordance with the present invention;





FIG. 14

is a schematic representation of the automated controls for the apparatus shown in

FIG. 12

, used to automate the production of retention catheters made in accordance with the present invention;





FIG. 15

is a transverse schematic view similar to that shown in

FIG. 11B

, but showing another embodiment with transition portions in the distal ends of balloon section and the reservoir section;





FIG. 16

is a transverse schematic view similar to that shown in

FIG. 15

, but showing-another embodiment with transition portions in both proximal and distal ends of the balloon section and the reservoir section;





FIG. 17

is a transverse schematic view of showing a cross-section of a catheter of

FIG. 1

when being inserted in an urethral tract of a patient, prior to the balloon section emerging into the bladder;





FIG. 18

is a view similar to that shown in

FIG. 17

, but showing the balloon section of the catheter having emerged into the bladder and is being inflated;





FIG. 19

is a transverse schematic view of another embodiment of an retention catheter in accordance of the present invention, similar to the view of

FIG. 1

;





FIG. 20

is a cross-sectional view of the retention catheter shown in

FIG. 19

as seen generally from the line


20





20


thereof;





FIG. 21

is an isometric view of another embodiment of a shaped structure made by the method according to the present invention; and





FIG. 22

is a cross-sectional view of yet another embodiment of a shaped structure made by the method according to the present invention.











DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS




The present method can be used to make many different shaped structures with a shaped overcoat. Various structures, ranging from simple structures, such as hoses, balloons, and the like, to more complex-shaped structures, such as condoms, urinary catheters with many portions of different geometries, and the like, can be made in with the method of the present invention.




In a preferred embodiment, the method of shaping a structure having a polymeric overcoat layer can be accomplished by first shaping a structure of bond-preventing agent and then coating the shaped structure of a bond-preventing agent with a polymeric bonding composition to form a shaped overcoat layer. The shaped structure of a bond-preventing agent can be formed by coating the outer surface of an inner piece, such a mandrel or a tube with a bond-preventing agent to result in a residual coating with a desired shape. The coating of the bond-preventing agent can have a varying thickness on different portions of an outer surface of the inner piece, which results in a particular shape in the shaped structure having a polymeric overcoat. The inner piece, if it has a lumen, is preferably made by a dipping process. Similarly, the residual coating and the overcoat layer are preferably made by respective dipping steps in appropriate liquid materials.




An embodiment of a female urinary catheter in accordance with of the principle of the present invention is shown in FIG.


1


. The catheter can be made with the above method or by other appropriate methods. This catheter


5


has an inner lumen


8


defined by an inner surface


10


of a tube


12


. An overcoat layer


14


encircles the tube


12


to define a cavity


16


. The cavity


16


contains a fluid


18


and has a fluid reservoir portion (or simply “reservoir portion”)


22


and a balloon portion


24


interconnected by a catheter sleeve portion (or simply “sleeve portion”)


26


such that fluid


18


can pass between the fluid reservoir portion


22


and the balloon portion


24


via the catheter sleeve portion


26


.




Such a catheter is a “hand-actuated retention catheter” and is useful in that a restriction means such as a restriction disc, clamp, elastomeric collar, or elastomeric collar


50


with a shroud


51


, can be used to encircle the sleeve portion


26


to restrict fluid from flowing from the balloon portion


24


to the reservoir portion


22


after the balloon portion has been expanded by squeezing the reservoir section of the overcoat (or “squeeze bulb”) by hand, thus maintaining the balloon portion


24


in an expanded state to retain the catheter in the desired location in a body passageway. The restriction means is preferably an elastomeric collar


50


with a shroud


51


for limiting the lateral bulging of the squeeze bulb when the squeeze bulb


30


is compressed, for example, between the thumb and the index finger. The restriction means can be loosened or removed to allow fluid to flow from the balloon portion when desired, thus deflating the balloon portion


24


to facilitate removal of the catheter from the body passageway. Preferably, the catheter


5


further includes a stylet for deploying the catheter in the urinary tract.




Method of Making Polymeric Shapes




To illustrate the application of the present method to forming a shaped, polymeric structure, the embodiment of making a female urinary catheter in accordance of the present invention is described in the following. This embodiment of a female urinary catheter (see

FIG. 1

) has various portions with different diameters. Referring now to

FIG. 2

, a resilient, polymeric tube


12


with a closed end, preferably a silicone rubber tube


12


, is to be formed first. Although the preferred material for the tube


12


is medically acceptable, silicone rubber, it is to be appreciated that other suitable, medically acceptable polymeric materials may be used. A silicone rubber tube can be made by dipping a mandrel in a polymeric dispersion containing uncured silicone rubber to form a coating and then curing the coating. The uncured silicone rubber for making the tubing is preferably one that will result in a silicone rubber of 50-70 durometer.




Referring now also to

FIGS. 3-14

, mandrels


62


, preferably made of a metal or alloy such as stainless steel or aluminum, are used for forming the catheter of the present invention. The mandrels are preferably coated with a polymer having low surface energy, such as tetrafluroethylene (e.g., TEFLON) so that the completed catheters can be readily removed from the mandrels.

FIG. 12

provides a schematic representation of a preferred mechanized catheter production line


81


which is virtually fully automated.

FIGS. 13A-C

highlights various steps of the automated method which is described below. The mechanized production line


81


includes one or more pallets


64


having a plurality of elongated mandrels


62


each having a generally round or blunt end distal to the pallet. The mandrel


62


preferably has an enlarged section corresponding to a connector portion (or an end piece)


80


proximate the pallet. The end piece


80


can have a transition portion that provides a gradual transition from the wider, proximal end of the end piece to the narrower, inner tubing of the catheter if desired. The moveable pallet


64


is attached to a transport mechanism


82


which can move the pallet to a position over one of a plurality of dip tanks


84


,


86


,


88


,


90


,


92


,


94


,


96


. Each of the respective dip tanks will contain a fluid in which mandrels


62


are immersed when the respective dip tank is raised. By dipping in the fluids in these dip tanks, a polymeric tube, shaped residual coating of a bond-preventing agent, and a polymeric overcoat layer are formed on the mandrel to result in a shaped, completed structure.




Movement of the pallet


64


is preferably controlled by an output from a computer control mechanism


83


, illustrated schematically in

FIG. 14

, which are directed to the transport mechanism


82


. Each of the respective dip tanks


84


,


86


,


88


,


90


,


92


,


94


,


96


are raised and lowered by associated lift mechanisms. The lift mechanisms are also preferably controlled by outputs from the computer control mechanism


83


. Each of the lift mechanisms includes a speed control capable of modulating the rate at which the respective dip tank is raised and lowered so that the speed at which the respective mandrels are immersed into and withdrawn from the respective fluid within the respective dip tank can be varied, either continuously or intermittently, and either during one dipping or between different dippings. The computer control mechanism


83


also receives inputs from depth sensors within each of the respective dip tanks. The depth sensors, preferably ultrasonic depth sensors, are capable of providing an input to the computer control mechanism


83


which enables the computer control mechanism to determine when the mandrels


62


are immersed to a desired depth in the respective dip tank. Timers are also provided for each of the respective dip tanks in order to provide inputs to the computer control mechanism


83


so that the computer control mechanism


83


can determine when a desired period of time has elapsed. A computer program is provided which moves the pallet along the mechanized production line


81


and raises and lowers the respective dip tanks at predetermined times, at predetermined rates of speed, and to predetermined locations and/or heights to enable the mechanized production line


81


to produce a plurality of completed catheters


4


by dipping the mandrels in various dip tanks of fluids. In alternate embodiments, the mechanized production line


81


may have a series of pallets (not shown) which are moved along an alternate transport mechanism (not shown) in series.




After a retention catheter is made, preferably, it is tested. During the testing of the completed retention catheter


5


, a removable cylindrical support device


98


is secured around the catheter sleeve section


34


of the overcoat layer


14


interposed between the balloon section


32


and the reservoir as shown in

FIG. 11B

, to minimize any potential expansion of the catheter sleeve section


34


. During testing, the balloon section


32


is expanded and stretched. The step of testing the balloon section


32


helps to create a retention catheter which has a readily expandable balloon section, as opposed to the catheter sleeve section


34


which does not expand as readily upon compression of the fluid reservoir section


30


. In addition, the balloon section can be inherently more readily expandable than the sleeve section due to its preferably larger diameter. After testing, the elastomeric collar


50


with a shroud


51


connected thereto is secured onto the catheter


5


by slipping the distal end


42


of the catheter


5


through the collar


50


until the collar encircles the catheter


5


on the catheter sleeve section


34


of the overcoat layer


14


just distal to the squeeze bulb


30


and the shroud encircles the squeeze bulb. In this way, when the squeeze bulb


30


is squeezed by the user, the shroud prevent the squeeze bulb from significantly stretching the portion of the reservoir section of the overcoat not being compressed to cause lateral ballooning (or bulging) thereof.




If desired, the polymeric tube can also be provided by either forming from a suitable tubing (e.g. medically adaptable silicone rubber tubing) purchased or made by an extrusion process known to those skilled in the art. The tubing can be cut to length, have a tip secured thereon, and then be secured to support rods, which can be attached to the pallet. The tip can be affixed to the tube, for example, by using an appropriate adhesive.




In the Applicants' use of the preferred methods of the present invention, production can be almost completely automated. Sets of polymeric structures such as catheters


5


can be manufactured simultaneously. In such preferred automated manufacturing process, the preferred pallet


64


has 400 TEFLON-coated stainless steel mandrels


62


attached to the pallet in 20 rows of 20 mandrels, wherein each of the mandrel


62


is about 1 inch (2.54 cm) from each adjacent mandrel.




Referring to

FIGS. 4-10

, in a preferred embodiment of the present method wherein the manufacturing process is automated for mass production of catheters, 400 of TEFLON-coated stainless steel mandrels are mounted vertically on a moveable pallet


64


. The pallet


64


is then moved via a transport mechanism


82


(see

FIG. 12

) over a series of dip tanks


84


,


86


,


88


,


92


,


94


,


96


as follows in one of these embodiments:




(A) The pallet


64


is transported to over a first tank


84


, which contains a polymeric bonding composition (e.g., an uncured silicone dispersion, for example, a mixture of uncured silicone rubber in toluene that is made by dispersing DOW CORNING Q7-4850 in the solvent (i.e., toluene). The tank


84


is then raised to immerse the mandrels in the uncured silicone dispersion to a depth to cover substantially the whole length of the mandrel such that the uncured silicone rubber dispersion covers the mandrel up to the level of dash line M. The dip tank


84


is then lowered and the outer surface of the mandrel from the distal end up to the dash line M in

FIGS. 3-4

is coated with a layer of the uncured silicone rubber dispersion, which is allowed to air-dry for the solvent to evaporate for about 8 minutes. The dipping step is repeated several times to obtain a desirable thickness of uncured silicone rubber coating corresponding to a desired cured silicone rubber thickness. The thickness of the inner tube is preferably about 0.89 mm (0.035 inch), plus or minus 0.1 mm (0.004 inch). The thickness of cured silicone rubber coating on the mandrel is selected such that the completed catheter can be deployed in the body by urging the catheter up the urethra (as shown in

FIG. 17

below) with a stylet inserted in the inner tube of the catheter and bearing or biasing against the tip of the inner tube without puncturing the inner tube. When the tank is lowered for the last time, the coating is allowed to air-dry for several minutes, preferably 10 minutes.




(B) The pallet


64


is then advanced to a dip tank (not shown) containing hot USP petrolatum heated to about 210° F. (99° C.) and the uncured silicone rubber coating on the mandrel is cured by dipping in the hot petrolatum for about 0.5 hour and the removed therefrom. Preferably, the cured silicone rubber coating on the mandrel is subsequently dipped in a volatile organic solvent such as toluene to remove all the petrolatum before the next dipping step. Alternatively, the curing can be done by removing the coated mandrels from the transport mechanism and placing them in a hot-air oven (220° F. or 104° C.) for about 0.5 hours to cure the uncured silicone rubber for forming an inner (or intermediate tube). After curing the silicone rubber, the pallet is again secured to the transport mechanism. “An intermediate tube” as used herein refers to a polymeric tube which can be coated with coating of a bond-preventing agent and overcoat layer to form a catheter. Alternatively, the individual mandrels can be placed in the oven separately. Another alternative is to heat the pallet with the mandrels and uncured silicone rubber coating in an oven designed for the whole pallet unit without removing the pallet from the transport mechanism in the production line.




(C) The pallet


64


is then moved and stopped over a second tank


86


, which contains a bond-preventing agent


66


, such as a petroleum jelly or petrolatum, preferably a liquid petrolatum mixture at about 125° F. (about 52° C.). The mixture will include Perfecta™ Petrolatum USP (from Sonneborn Petrolatums, Sonneborn Div., Witco Chemical Corp., New York, N.Y.). The tank is raised so as to immerse the intermediate tubes


3


into the petrolatum to such a depth (up to dashed line A shown in

FIGS. 5 and 6

) that the petrolatum coats the first, second, third and fourth portions


20




a


,


20




b


,


20




c


and


20




d


of the outer surface


20


of the intermediate tubes


3


. The dip tank


84


is then lowered and these portions of the outer surface


20


are coated with a first coating


75


of petrolatum. The tubes


3


are allowed to air-dry and cool for about 30-60 seconds, and the dip tank is raised again and the tubes


3


are immersed again to the same depth. This is repeated


1015


times until the first coating


75


is built up to a desired thickness (referred to as coating


76


in the drawing, see FIGS.


5


and


6


). The desired thickness of the first coating


76


on the tube


3


corresponds to the desired thickness of the reservoir portion


22


of the cavity. Preferably, this thickness is about 1 cm to 2 cm (0.4 in to 0.8 inch) such that the resulting reservoir section of the completed catheter will not be inadvertently drawn into the urethra.




(D) The pallet


64


is then automatically advanced and stopped over a third dip tank


88


which contains hot USP petrolatum heated to about 180° F. (about 82° C.). The third dip tank


88


is raised so as to immerse the intermediate tubes


3


into the super-heated petrolatum for 1 minute so that the super-heated petrolatum comes up to dashed line B-and into contact with the first coating


76


on the second, third and fourth portions


20




b


,


20




c


and


20




d


of the outer surfaces


20


of the intermediate tubes


3


from the prior dipping step. The third dip tank


88


is then lowered. This dipping step causes the coating


76


of petrolatum from the prior dipping step to be largely removed (or stripped) from the second, third and fourth portions


20




b


,


20




c


and


20




d


of the outer surface


20


of the intermediate tubes


3


, as shown in FIG.


7


. Some residual petrolatum may remain on these portions of the outer surface


20


. However, most of the petrolatum is removed from them. The time of dwelling and/or the rate of withdrawal of the mandrels from the stripping fluid can be varied to effect a gradual reduction of the diameter of the distal portion of the first coating


76


remaining on the mandrel, thereby forming a transition portion in the second portion. For example, the time of dwelling of the proximal part of the first coating


76


on the


20




b


portion of the surface


20


in the stripping fluid can be less than the time of dwelling of the more distal part of the same portion to allow more time to strip the distal portion. This can be accomplished, for example, by lowing the dip tank from the dash line B at a decreasing rate for a distance desired for the transition portion.




(E) The pallet


64


is then automatically advanced and stopped over a fourth dip tank


90


containing a liquid petrolatum mixture identical to that in the second dip tank


86


, except that the temperature is about 135° F. (about 57° C.). The fourth dip tank


90


is then raised so as to immerse the intermediate tubes


3


into the petrolatum mixture to the same depth as they were immersed in the super-heated petrolatum in the third dip tank


88


. In the case where there is a transition portion on the coating remaining on the intermediate tube after the stripping step, the tank is raised to a depth so as to just immerse the distal end of the transition portion. The tank


90


is then lowered, leaving a coating


77


(referred to as the second coating to distinguish from the first coating) of petrolatum on the second, third and fourth portions


20




b


,


20




c


and


20




d


of the outer surface


20


, as shown in FIG.


8


. If desired, this step can be repeated a few times to build up the thickness of the second coating to have an outside diameter generally corresponding to the diameter of the urethra. The tubes are then immersed again up to the dashed line C and a third coating


78


is created over the third and fourth portions


20




c


and


20




d


of the outer surface


20


(as shown in FIG.


9


). Preferably, the dipping step is repeated to build up the the third coating


78


to that it is somewhat thicker than the second coating


77


but thinner than the first coating


76


.




(F) The pallet


64


is then automatically advanced and stopped over a fifth dip tank


92


containing hot USP petrolatum like that in the third dip tank


86


. The fifth dip tank


92


is raised and the tubes


3


are immersed in the super-heated petrolatum up to the dashed line D for about


30


seconds. The fifth dip tank is then lowered and the third coating


78


of petrolatum is removed from the fourth portion


20




d


of the outer surface


20


, as shown in FIG.


10


. As before, if desired, a transition portion can be formed by lowering the dip tank


92


gradually or at a decreasing rate once the dip tank has been raised to the desired position. In addition, if desired, part of the residual coatings remaining on the intermediate tube can be further shaped by mechanically removing some of the coatings, for example, by using a knife-like device to sculpture specific shapes thereon.




(G) The pallet


64


is then automatically advanced and stopped over a sixth dip tank


94


containing a volatile organic solvent such as toluene, xylene, or the like, effective to remove all of the bond-preventing agent therefrom so that there will be no interference with the subsequent bonding of silicone rubber to the intermediate tube. The fifth tank


94


is then raised to immerse the intermediate catheters


3


in the organic solvent up to dashed line D (or up to the distal end of the transition portion in the portion


20




d


below the dash line D if a transition portion is present) so as to remove any remaining petrolatum


66


on the fourth portion


20




d


of the outer surface


20


. The intermediate catheter tubes


3


now have three bands


76


,


77


and


78


of semi-solid petrolatum around the axial circumference of each of the intermediate tubes


3


, as shown in FIG.


10


.




(H) The tank


64


is then lowered, and the organic solvent is allowed to evaporate from the outer surface


20


for about 15 minutes. The pallet


64


is then automatically advanced to a seventh dip tank


96


containing a hexamethyl disiloxane silicone rubber dispersion which is effective to minimize any disruption of the integrity of the petrolatum coatings


76


,


77


and


78


remaining on the intermediate tubes


3


. Although the present retention catheter


5


can be constructed of any suitable, medically acceptable, polymeric material, medical grade silicone rubber is preferred. The silicone rubber of the sleeve overcoat preferably is soft, with a hardness of about 20 to 40 durometer, more preferably about 30 durometer. It will be appreciated that such a silicone rubber polymeric must be fully cured prior to sale or use. The overcoat layer can have a thickness of about 0.1 mm to 1 mm, preferably about 0.35 mm plus or minus 0.06 mm (0.0175 inch plus or minus 0.0025 inch). The preferred uncured silicone rubber dispersion is a very soft uncured silicone rubber dissolved in weak solvent that will not attack petroleum jelly. An effective uncured silicone rubber dispersion for making the present invention is a 25-75 mixture of uncured silicone rubber in hexamethyl disiloxane. This mixture is made of GE 603015 LIQUID SILICONE RUBBER and hexamethyl disiloxane. Another example of such an uncured silicone rubber dispersion is Dow Corning Q7-4720 in hexamethyl disiloxane. The seventh dip tank


94


is then raised to immerse essentially the entire length of the intermediate tube


3


in the silicone mixture. This step is preferably subsequently repeated 4-6 times at


8


minute intervals to allow time for significant solvent evaporation. When the tank


96


is lowered for the last time, the overcoat layer


14


is allowed to dry and the solvent is allowed to evaporate for about 30 minutes, preferably about an hour. If transition portions are provided on the distal portions of the first coating (in second portion


20




b


) and the third coating (in fourth portion


20




d


) as described hereinabove, the resulting completed catheter will have features shown in

FIG. 15

, which shows a transition portion of a balloon section and a transition portion of a reservoir section.




(I) In a preferred embodiment of the present method, the pallet


24


is advanced to yet another dip tank (not shown) similar to the others, but containing hot USP petrolatum, heated to about 210° F. (about 99° C.). The tubes


3


are completely immersed in the hot petrolatum for 1 hr to cure the uncured silicone rubber and form the completed intermediate catheters


4


shown in

FIG. 11A

, and the tank (not shown) is then lowered.




(J) The completed intermediate catheters


4


are then removed from the pallets and further cured in hot air at 220° F. (about 104° C.) for about an hour and a half (1.5 hrs).




(K) After the completion of the heat cure, the intermediate catheters


4


are allowed to cool before forming an eyelet


40


each thereon to form the completed retention catheter


5


. Preferably, the intermediate catheters are soaked in hot mineral oil at 250° F. (121° C.) for 24-48 hours. The intermediate catheters


4


are then removed from the oil and preferably cleaned.




(L) The completed catheters


5


are finished by punching the fluid conduit access opening or eyelet


40


in the exterior surface


36


of each catheter such that the opening communicates with the fluid conduit lumen


8


in a location below or distal to the balloon section


32


. In a device not used for draining fluid, such is a device used for blocking a passageway, for example, for stopping fluid leakage therethrough, such an eyelet may not be needed.




(M) If not previously soaked in mineral oil, the completed catheters


5


are then soaked for preferably


24


to 48 hrs in a hot bath of mineral oil at 250° F. (about 121° C.). The mineral oil will generally replace the petrolatum


66


in the cavity


16


after this period of time, and will remain a fluid


18


at room temperature. The mineral oil has a significantly lower viscosity than petrolatum at room temperature. A different fluid such as water, sterile saline, glycerin, polyethylene glycol, gas (e.g., air) and the like, or appropriate mixtures thereof may also be substituted for the mineral oil/petrolatum fluid in alternate embodiments by removing most of the latter fluid, and then inserting the former by an appropriate means.




(N) The expandable balloon section


32


is then tested and stretched, and then an elastomeric collar


50


with a shroud


51


is put into place over the sleeve section


34


and the reservoir section


30


of the overcoat by slipping over the distal portion of the catheter from the distal end. The completed catheters


5


are packaged and then sterilized prior to shipment.




The above process of shaping the preferred embodiment of a hand-actuated catheter is summarized in the flow diagrams in

FIGS. 13A

,


13


B and


13


C. The automated method that Applicants claim can permit completed catheters


5


to be manufactured at the rate of about 1,600 catheters per hour. Because little handwork is involved, the catheters


5


produced will be consistent, of very high quality, and less costly to produce than comparable prior art catheters. The exterior surface


36


is believed to be smoother and softer than the exterior surface of hand-glued balloons.




The method of the present invention can be used to make structures having an overcoat layer encircling an inner piece wherein the size of the cavity and the number of cavities can be different from the embodiments described hereinabove. The cavities can be isolated from each other or one or more of the cavities can be connected together to have fluid communication. For example, the cavity defined between an overcoat and the inner tube can have sections with different sizes (such as fluid reservoirs, sleeve cavities, balloons as in the embodiment described hereinabove). Some of the cavities may also be linked by fluid communication means that is not defined between the overcoat layer and the inner tube. These variations affects the shape of the final structure with the overcoat layer, e.g., a catheter. Also, any structure or object, e.g. a conical tip, affixed to the inner piece, e.g., a tube, will also affect the shape of the final structure when the overcoat layer is shaped.




The method can be used to make structures having transition portions on both ends. One embodiment of the process for making a transition portion gradually narrowing distally has been described hereinabove. Transition portions on the proximal ends can be made by immersing the inner piece, e.g., intermediate tube, to a lesser depth in the bond-preventing agent in each succeeding, thickness-building dipping step during the multiple-dipping process in the formation of the residual coating (e.g. the first and the third coating of the bond-preventing agent of FIG.


10


). By this method, the proximal ends of the first and third coatings narrow gradually in the proximal direction. By providing such transition portions, structures with various portions of different size can be made to have gradual change rather than abrupt change in shape, for example, a female urinary catheter as shown in FIG.


16


.




As previously stated, the present method can be used to make structures that contain a fluid, such as mineral oil. Furthermore, if desired, the completed shaped structure can be a hollow structure, such as a hollow or air-filled balloon. In this case, the inner piece can be pulled from the overcoat layer and the bond-preventing agent or liquid (such as mineral oil) can be squeezed out of the inside cavity of the completed shaped structure. The inner piece can be pulled from the overcoat layer if the inner piece is not in direct contact with the overcoat, as in the case wherein a coating of bond-preventing agent is disposed between the inner piece and the overcoat layer over all the area of the overcoat layer. In another embodiment, the inner piece is coated with a release layer such as TEFLON so that an overcoat layer is not irremovably bonded to it. If desired, the bond-preventing agent can be left in the cavity enclosed by the overcoat layer. As previously stated, the present method can be used to make a simple structure such as a condom. This can be done by a process which includes dipping a mandrel in a bond-preventing for form the shaped structure of bond-preventing agent and coating this structure with a polymeric bonding composition. Depending on the polymeric composition used, a curing step may or may not be necessary. The mandrel and the bond-preventing agent can be removed from the completed condom with appropriate methods.




Therefore, based on the present invention, one can make structures, such as hoses, balloons, condoms, cannulas, catheters, and the like, with one or more sections with different diameters, lengths, or shapes. For example, a hollow structure with a polymeric overcoat of a shape shown in

FIG. 21

, which has a hollow disc


202


interconnecting and disposed between a first tubular structure


204


and a second tubular structure


206


can be made. Another example is a generally umbrella-shaped polymeric structure as shown in FIG.


22


. This generally umbrella-shaped structure


210


has, for example, a cylindrical inner piece (or shaft)


212


(which can be a rod or a tube) and a bowl-shaped outer piece (or hood)


214


integrally connected to an end of the inner piece. The hood encircles the shaft at least partially (e.g., the distal portion or entire length) and defines a recess


216


in cooperation with the shaft at the distal end of the shaft. The periphery of the hood is not attached to the shaft. This structure can be made by a method that includes first forming a cylindrical polymeric inner piece (which can be made by injection molding or by coating a mandrel to form a tube and filling the tube with polymeric material to form a rod), coating the cylindrical inner piece with a residual coating of bond-preventing agent, stripping away the distal portion of the residual coating of bond-preventing agent up to the end of the cylindrical inner piece, and subsequently coating the distal portion of the cylindrical inner piece and the residual coating with a polymeric bonding composition without completely encapsulating or covering the proximal portion of the residual coating. By varying detailed steps of the method, other structures with recesses of various shapes can be formed.




Female Urinary Catheter




The female urinary catheter of the present invention is a hand-actuated retention catheter which is similar to the hand-actuated retention catheter disclosed in U.S. patent application Ser. No. 07/827,936, filed Jan. 29, 1992, the method of making, characteristics, and use of which are incorporated by reference herein. The preferred embodiment (shown in

FIG. 1

) of the hand-actuated retention catheter


5


of the present invention comprises a tube


12


having outer surface


20


and inner surface


10


and an overcoat layer


14


. The tube


12


has an inner lumen


8


which is defined by the inner surface


10


of the tube. The overcoat layer


14


encircles the tube


12


and has interior and exterior surfaces. A cavity


16


is interposed between the tube


12


and the overcoat layer


14


. This cavity


16


also encircles the tube


12


and is defined by portions of the outer surface


20


of the tube


12


in cooperation with portions of the interior surface of the overcoat layer


14


. This cavity


16


preferably contains a fluid


18


, although it can contain a soft, moldable semisolid such as petroleum jelly, or the like, or a combination thereof instead. The overcoat layer


14


includes an expandable, resilient balloon section


32


proximate a distal end, a reservoir (or bulbous) section


30


proximal thereto, and a catheter sleeve section


34


disposed therebetween. The sleeve section


34


interconnects the balloon section


32


and the reservoir section


30


. The overcoat layer


14


is joined to the outer surface


20


of the tube


12


at the distal and proximal ends of the cavity


16


(i.e., above and below the cavity) along the tube. The cavity


16


also includes a balloon portion


24


, a reservoir portion


22


, and a catheter sleeve portion


26


that interconnects the balloon portion and the reservoir portion. The catheter sleeve section


34


of the overcoat layer defines a narrowing in cavity through which fluid passes if made to flow between the balloon portion


24


to the reservoir portion


22


. Each of the sections can be cylindrical in shape, or a transition portion that narrows gradually can be provided on one or both ends of the balloon section and/or the reservoir section to facilitate smooth insertion and withdraw of the catheter into the body. The balloon section of the overcoat and the balloon portion of the cavity are of a size such that when the balloon is expanded, it is effective to prevent withdrawal of the balloon section into the urethra in contact with the catheter. Disposed on the sleeve section


34


proximate the squeeze bulb


30


is an elastomeric collar


50


with a shroud


51


, which encloses the squeeze bulb. The shroud


51


is preferably, but not necessarily, unitary and integral with the collar


50


. The shroud


51


can be connected with the outer edge of the collar


50


such that they resemble a cylindrical cap with an end disc having an opening in the center of the end disc. In another embodiment (not shown), the shroud can be separate from the collar and the shroud can have an ellipsoid shape with open ends which have diameters larger than that of the sleeve section


34


to generally conform to the shape of the reservoir section


30


.




The collar


50


presses radially inward on the sleeve so that fluid is prevented from flowing from the balloon portion of to the reservoir portion of the cavity during normal, everyday activities of the user. However, when the catheter is being deployed, the fluid can be deliberately forced past the sleeve section of the cavity by squeezing the squeeze bulb, thus forcing the inside diameter of the collar to slightly increase. In this manner, the balloon section is expanded (i.e. inflated) to retain the catheter in the body passageway.




Preferably, the collar


50


and shroud


51


are made of a material soft and resilient enough such that when desired, they can be readily pulled along the catheter over the reservoir section. Preferably, the shroud


51


is generally cylindrical with an inside diameter of about the outside diameter of the squeeze bulb so that it can be readily slipped over the squeeze bulb


30


during assembly of the catheter. When a force is not being applied from an external source, as by compressing with a thumb and a finger, preferably the shroud does not compress the squeeze bulb. Without the shroud


51


, when the squeeze bulb


30


is


43


squeezed to force the fluid from the reservoir portion


22


to the balloon portion


24


through the sleeve portion


26


of the cavity, for example, as when being compress between the thumb and index finger of an user, because of the resistance to fluid flow caused by the restricting collar, the squeeze bulb


30


has a tendency to balloon or bulge out in a direction perpendicular to the direction of the applied compression force, i.e. generally lateral to the axis of the catheter. This is because when compressing forces are not applied in an enveloping manner on the squeeze bulb, the fluid in the squeeze tends to balloon out at the locations with the least compressing force. Such lateral ballooning in the squeeze bulb


30


decreases the efficiency of the squeezing action and make it relatively difficult to expand the balloon portion


24


of the cavity. A shroud


51


encircling the squeeze bulb


30


inhibits he lateral ballooning of the squeeze bulb as it is being squeezed, thus directing the compressing force of the squeezing action to force the fluid to increase the inside diameter of the collar. In this way, fluid is passed to expand the balloon portion


24


. The shroud


51


is preferably constructed of a silicone rubber which is soft and pliable and has a thickness making it relatively less stretchable than the overcoat layer on the squeeze bulb


30


and the balloon section


32


so that the shroud can inhibit the lateral ballooning of the squeeze bulb


30


when the squeeze bulb is compressed to force fluid past the sleeve section restricted by the collar


50


. The elastomeric collar and shroud can be made with the same silicone rubber material that is used for constructing the inner polymeric tube


12


or the overcoat layer


14


. The elastomeric collar and shroud can be made with conventional methods such as injection-molding, or if preferred, with an overcoat-shaping method through dipping in a polymeric material similar to that described above.




The female urinary catheter described hereinabove can be used in the following fashion. Referring to

FIGS. 17-18

, first, an elongated, stiff, but slightly flexible stylet


104


is removably inserted into the catheter


5


through the opening at the connector or end piece


80


. Such a stylet is preferably made with- plastic and has a diameter slightly smaller than the inside diameter of the inner tube of the catheter for easy insertion and withdrawal. The stylet preferably has a round or blunt distal end


106


and a proximal end having a generally flat end portion


108


generally perpendicular to the elongated part of the stylet. If desired, the flat end portion can extend with its plane parallel to the axis of the stylet. The proximal end portion


108


of the stylet can also be of a shape (e.g., bulb-shaped) for a person's hand to comfortably press thereon to urge the stylet into the catheter and bear against the tip of the catheter. The length of the stylet is slightly longer than the length of the catheter such that when inserted all the way inside a catheter with the distal end of the stylet bearing against the tip of the catheter, the proximal end portion


108


of the stylet


104


is outside and proximal to the end piece


80


of the catheter


5


.




The tip of the catheter is then inserted into the urethral tract


120


. By generally pressing on the proximal end portion


108


of the stylet, the balloon section of the catheter is slowly urged into the urethral tract. The catheter is slowly advanced into the urethra until the balloon section


32


reaches and emerges into the space inside the bladder


128


and the squeeze bulb (or reservoir section)


30


of the catheter reaches the external opening of the urethra.




Referring to

FIG. 18

, after the balloon section


32


emerges from the urethra, the squeeze bulb


30


, encircled by the shroud


51


, is squeezed, for example, between a thumb and an index finger, to force the fluid


18


from the reservoir portion


22


into the balloon portion


24


through the sleeve portion


26


. Strong enough forces are applied (the directions of application are shown by the arrows P and Q) to overcome the compression force by the collar


50


so that fluid can pass through the sleeve portion


26


to inflate the balloon section of the overcoat


32


. The shroud


51


inhibits any significant ballooning of the squeeze bulb


30


in a direction perpendicular to the applied forces P and Q. The collar


50


prevents fluid that has been previously forced out of the reservoir portion of the cavity from flowing back thereinto, thus maintaining the balloon portion


24


in an expanded state to retain the catheter in the desired location in a body passageway. The urethral (or sleeve) section


34


of the catheter can softly conform to the wall of urethral tract to provide a gentle leak-proof fit. The stylet


104


is then withdrawn from the catheter


5


by grasping the catheter to maintain it in place as the stylet is gently pulled out of the catheter. Alternatively, the stylet


104


can be withdrawn before the balloon portion


24


is expanded. The end piece


80


of the catheter is connected to a connector tube which leads to a bag for holding urine.




To remove the catheter from the body, the shroud


51


can be grasped by hand and gently pulled while the sleeve section


34


of the catheter is firmly held so that the collar


50


with shroud


51


is slipped proximally over the reservoir section


30


. If the collar


50


and the shroud


51


are separate, the collar can be similarly removed by pulling. Subsequently, the sleeve portion


26


of the cavity, no longer being restricted by the collar


50


, allows the fluid to freely return from the balloon portion


24


to the reservoir portion


22


, thus deflating the balloon portion to facilitate the removal of the catheter from the body passa way.




The catheter of the present invention can be made so that the enclosed cylindrical sleeve cavity contains a lubricant. An example of lubricant effective for lubricating the sliding of the overcoat on the surface of inner tube and reduction of friction is petrolatum or liquid soap. The lubricant and the method of incorporating the lubricant into the cavity as disclosed in U.S. Pat. No. 5,098,379 (Conway et al.) are incorporated by reference herein.




The female catheter can also include bactericidal agents. One embodiment is to incorporate the bactericidal agents into the polymeric matrix of at least a portion of the overcoat layer of the cannula or catheter. The polymeric matrix preferably includes cured silicon rubber. The bactericidal agent and the method of incorporating such bactericidal agent into the matrix of the overcoat layer as disclosed in U.S. Pat. No. 5,261,896 (Conway et al.) are incorporated by reference herein. Another method of providing bactericidal effect by the catheter is to incorporate bactericidal agents in the substance, such as a lubricant, contained in the cavity defined by the overcoat layer and the inner tube with a means provided for the diffusion of the bactericidal agents out of the cavity. The bactericidal agents and the method of incorporating these agents into the catheter as disclosed in U.S. Pat. No. 5,269,770 (Conway et al.) are incorporated by reference herein.




Another embodiment is a catheter (as shown in

FIGS. 19-20

) having channel


27


in the wall of the inner tube that provides fluid communication between the balloon cavity


24


″ and the reservoir cavity


22


″ (the features of the primed numbers in

FIGS. 19-20

correspond to the features of corresponding numbers in FIG.


1


). The reservoir cavity


22


″ has a cylindrical narrow portion


26


″ distal thereto extending toward but not communicating with the reservoir cavity


22


″. The channel enters the balloon portion


24


″ of the cavity at an opening


25


and enters the cylindrical, narrow portion


26


″ of the reservoir cavity at an opening


23


. Such an inner tube can be made by injection molding. Another embodiment is a catheter similar to the retention catheter described hereinabove in

FIG. 1

with the differences that the balloon section of the catheter has a much larger geometry (i.e., diameter) than that shown in FIG.


1


. If preferred, catheters with more than one cavity wherein the cavity has one or more portions of different diameters can be made with the method of the present invention.




A catheter of the present invention can also be packaged in a vapor barrier pack (such as metal foil or plastic) with a stylet inserted in the catheter to reduce the loss of fluid. Such a package can be sold as a kit commercially.




It is to be understood that even though numerous characteristics and advantages of the present invention have been set forth in the foregoing description, together with details of the structure and function of the invention, the sequence or order of the specific steps, or the actual compositions, solvents, temperatures, environmental conditions and the like employed for each step, it will be appreciated the disclosure is illustrative only, and that changes may be made in detail, especially in matters of shape, size, arrangement of parts or sequence or elements of events within the principles and spirit of the invention. For example, in making a shaped structure with the method of the present invention, the liquid composition for forming the inner piece can be a nonpolymeric material such as a composition containing an inorganic dispersion such as clay or a molten metal such as lead. Likewise, the liquid composition for coating the bond-preventing agent need not be polymeric.



Claims
  • 1. A method of catheterizing a patient, comprising:urging a hand-actuated retention catheter into a body passageway from a space exterior thereto, said catheter comprising a tube having outer and inner surfaces, the inner surface defining an inner lumen, an overcoat layer encircling the tube, the overcoat layer having interior and exterior surfaces, a cavity interposed between the tube and the overcoat layer, a fluid within the cavity, and a restriction collar with a shroud; said cavity encircling the tube and being defined by portions of the outer surface of the tube in cooperation with portions of the interior surface of the overcoat layer, wherein the overcoat layer includes an expandable, resilient balloon section, a fluid reservoir section proximal thereto, and a catheter sleeve section interconnecting said balloon section and said reservoir section, each of such sections corresponds to a corresponding section of the catheter; the overcoat layer being joined to the outer surface of the tube at distal and proximal ends of the cavity; the cavity including a balloon portion, a fluid reservoir portion, and a catheter sleeve portion thereof interconnecting said balloon portion and said reservoir portion; wherein the catheter sleeve section of the overcoat layer defines a narrowing in cavity through which fluid passing from the fluid reservoir portion and the balloon portion thereof must pass; the collar being encircling the sleeve section to restrict flow in the sleeve portion of the cavity and the shroud encircling the reservoir section to limit the lateral ballooning thereof; compressing the shroud-encircled reservoir section to force fluid through the sleeve portion to the balloon portion of the cavity; and subsequently removing the collar with the shroud from the catheter to enable withdrawal of the catheter from the body passageway.
  • 2. The method of claim 1 wherein the step of urging the catheter is a result of pushing a stylet inserted into the lumen of the inner tube.
CROSS-REFERENCE TO OTHER APPLICATIONS

The present application “is a file wrapper continuation of application Ser. No. 08/413,698, filed Mar. 30, 1995, which is a divisional of application Ser. No. 08/285,026, filed Aug. 2, 1994 now U.S. Pat. No. 5,670,111, which” is a continuation-in-part application of U.S. patent application Ser. No. 07/827,936, filed Jan. 29, 1992 now U.S. Pat. No. 5,360,402, which is a continuation-in-part application of U.S. patent application Ser. No. 07/809,281, filed Dec. 13, 1991 now U.S. Pat. No. 5,261,896, which is a continuation-in-part of U.S. patent application Ser. No. 07/489,462, filed Mar. 6, 1990 now abandoned, which is a continuation-in-part application of U.S. patent application Ser. No. 07/487,422, filed Mar. 1, 1990 now U.S. Pat. No. 5,098,379, which is a continuation-in-part application of U.S. patent application Ser. No. 07/462,832, filed Jan. 10, 1990 now U.S. Pat. No. 5,137,671, the disclosures of which are each incorporated herein by reference.

US Referenced Citations (159)
Number Name Date Kind
1235142 Ichilian Jul 1917 A
1643289 Peglay Sep 1927 A
2043630 Raiche Jun 1936 A
2228992 Frey Jan 1941 A
2230226 Auzin Apr 1941 A
2248934 Auzin Jul 1941 A
2308484 Auzin et al. Jan 1943 A
2314262 Winder Mar 1943 A
2320157 Raiche May 1943 A
2322858 Limbert et al. Jun 1943 A
2330399 Widner Sep 1943 A
2330400 Winder Sep 1943 A
2390070 Auzin Dec 1945 A
2481488 Auzin Sep 1949 A
2610626 Edwards Sep 1952 A
2649619 Killian Aug 1953 A
2690595 Raiche Oct 1954 A
2712161 Moss Jul 1955 A
3044468 Birtwell Jul 1962 A
3053257 Birtwell Sep 1962 A
3076464 Rosenburg Feb 1963 A
3169527 Sheridan Feb 1965 A
3211151 Foderick et al. Oct 1965 A
3304353 Harautuneian Feb 1967 A
3394705 Abramson Jul 1968 A
3409016 Foley Nov 1968 A
3463141 Mozolf Aug 1969 A
3503400 Osthagen et al. Mar 1970 A
3508959 Krahnke Apr 1970 A
3509884 Bell May 1970 A
3539674 Dereniuk et al. Nov 1970 A
3544668 Dereniuk Dec 1970 A
3548805 Datsenko et al. Dec 1970 A
3556294 Walck, III et al. Jan 1971 A
3566874 Shepherd et al. Mar 1971 A
3593713 Bogoff et al. Jul 1971 A
3598127 Wepsic Aug 1971 A
3606889 Arblaster Sep 1971 A
3642004 Osthagen et al. Feb 1972 A
3683928 Kuntz Aug 1972 A
3695921 Shepherd et al. Oct 1972 A
3699956 Kitrilakis et al. Oct 1972 A
3708324 Stebleton Jan 1973 A
3797478 Walsh et al. Mar 1974 A
3838728 Voegel Oct 1974 A
3841304 Jones Oct 1974 A
3854483 Powers Dec 1974 A
3875937 Schmitt et al. Apr 1975 A
3879516 Wolvek Apr 1975 A
3882220 Ryder May 1975 A
3889685 Miller, Jr. et al. Jun 1975 A
3894540 Bonner, Jr. Jul 1975 A
3903893 Scheer Sep 1975 A
3924634 Taylor et al. Dec 1975 A
3926705 Todd Dec 1975 A
3981299 Murray Sep 1976 A
4029104 Kerber Jun 1977 A
4062363 Bonner et al. Dec 1977 A
4133303 Patel Jan 1979 A
4149539 Cianci Apr 1979 A
4196731 Laurin et al. Apr 1980 A
4198984 Taylor Apr 1980 A
4225371 Taylor et al. Sep 1980 A
4249535 Hargest, III Feb 1981 A
4265848 Rüsch May 1981 A
4266999 Baier May 1981 A
4269310 Uson May 1981 A
4284459 Patel et al. Aug 1981 A
4311146 Wonder Jan 1982 A
4311659 Rey et al. Jan 1982 A
4318947 Joung Mar 1982 A
4378796 Milhaud Apr 1983 A
4381008 Thomas et al. Apr 1983 A
4381380 LeVeen et al. Apr 1983 A
4395806 Wonder et al. Aug 1983 A
4457299 Cornwell Jul 1984 A
4472226 Redinger et al. Sep 1984 A
4479795 Mustacich et al. Oct 1984 A
4515593 Norton May 1985 A
4539234 Sakamoto et al. Sep 1985 A
4553533 Leighton Nov 1985 A
4563184 Korol Jan 1986 A
4571239 Heyman Feb 1986 A
4571240 Samson et al. Feb 1986 A
4581026 Schneider Apr 1986 A
4581028 Fox, Jr. et al. Apr 1986 A
4582762 Onohara et al. Apr 1986 A
4592920 Murtfeldt Jun 1986 A
4601713 Fuqua Jul 1986 A
4603152 Laurin et al. Jul 1986 A
4612337 Fox, Jr. et al. Sep 1986 A
4622033 Taniguchi Nov 1986 A
4623329 Drobish et al. Nov 1986 A
4627844 Schmitt Dec 1986 A
4634433 Osborne Jan 1987 A
4637907 Hegel Jan 1987 A
4652259 O'Neil Mar 1987 A
4664657 Williamitis et al. May 1987 A
4677143 Laurin et al. Jun 1987 A
4686124 Onohara et al. Aug 1987 A
4687470 Okada Aug 1987 A
4692152 Emde Sep 1987 A
4710169 Christopher Dec 1987 A
4710181 Fuqua Dec 1987 A
4731064 Heyden Mar 1988 A
4737219 Taller et al. Apr 1988 A
4739768 Engelson Apr 1988 A
4747845 Korol May 1988 A
4769013 Lorenz et al. Sep 1988 A
4772473 Patel et al. Sep 1988 A
4775371 Mueller, Jr. Oct 1988 A
4813935 Haber et al. Mar 1989 A
4820270 Hardcastle et al. Apr 1989 A
4820292 Korol et al. Apr 1989 A
4838876 Wong et al. Jun 1989 A
4850969 Jackson Jul 1989 A
4861337 George Aug 1989 A
4863424 Blake, III et al. Sep 1989 A
4863444 Blomer Sep 1989 A
4874373 Luther Oct 1989 A
4876109 Mayer et al. Oct 1989 A
4902503 Umemura et al. Feb 1990 A
4904260 Ray et al. Feb 1990 A
4917686 Bayston et al. Apr 1990 A
4923450 Maeda et al. May 1990 A
4925668 Kahn et al. May 1990 A
4930522 Busnel et al. Jun 1990 A
4932938 Goldberg Jun 1990 A
4935260 Shlenker Jun 1990 A
4950256 Luther et al. Aug 1990 A
4968507 Zentner et al. Nov 1990 A
4976703 Franetzki et al. Dec 1990 A
4981471 Quinn et al. Jan 1991 A
4994047 Walker et al. Feb 1991 A
5013306 Solomon et al. May 1991 A
5013717 Solomon et al. May 1991 A
5019096 Fox, Jr. et al. May 1991 A
5019378 Allen May 1991 A
5019601 Allen May 1991 A
5071406 Jang Dec 1991 A
5078707 Peter Klug Jan 1992 A
5082006 Jonasson Jan 1992 A
5089205 Huang et al. Feb 1992 A
5090424 Simon et al. Feb 1992 A
5098379 Conway et al. Mar 1992 A
5112306 Burton et al. May 1992 A
5128088 Shimomura Jul 1992 A
5131906 Chen Jul 1992 A
5137671 Conway et al. Aug 1992 A
5165952 Solomon et al. Nov 1992 A
5176666 Conway et al. Jan 1993 A
5261896 Conway et al. Nov 1993 A
5269770 Conway et al. Dec 1993 A
5290306 Trotta et al. Mar 1994 A
5306226 Salama Apr 1994 A
5360402 Conway et al. Nov 1994 A
5370899 Conway et al. Dec 1994 A
5395333 Brill Mar 1995 A
5415635 Bagaoisan et al. May 1995 A
Foreign Referenced Citations (18)
Number Date Country
763930 Jul 1967 CA
352014 Apr 1922 DE
41-35502 Feb 1993 DE
0055023 Jun 1982 EP
0 184 629 Jun 1986 EP
0 303 487 Feb 1989 EP
2351634 Dec 1977 FR
2150938 Jul 1985 GB
2187670 Sep 1987 GB
0218157 Dec 1984 JP
0228856 Dec 1984 JP
278468 May 1970 RU
8401102 Mar 1984 WO
8909626 Jan 1989 WO
9004431 May 1990 WO
WO 9110466 Jul 1991 WO
WO 9208426 May 1992 WO
WO 9314806 Aug 1993 WO
Non-Patent Literature Citations (20)
Entry
“The Merck Index: Ninth Edition”, 1976, Merck and Co., Inc., p. 857.
Bayston, “The Antibacterial Effects of Impreganted Silastic and its Possible Applications in Surgery”, J. Pediatric Surgery, 12, 55-61 (1977).
Bayston, “Preliminary Studies on the Impregnation of Silastic Elastomers with Antimicrobial Substances”, Devel. Medicine and Child Neurol., Suppl. (37): 50-54 (1976).
Butler et al., “Evaluation of Polymyxin Catheter Lubricant and Impregnated Catheters”, J. Urology, 100, 560-566 (1968).
S. M. Lazarus et al., “A Hydrophilic Polymer-Coated Antimicrobial Urethral Catheter”, J. Biomed Mater. Res., 5, 129-138 (1971).
J. C. Brocklehurst et al., “The Management of Indwelling Catheters”, Brit. J. Urology, 50(2): 102-105 (1978).
A. M. Johansen and B. Sorensen, “Scand. J. Plast. Reconstr. Surg.” 6(1): 47-50 (1972).
K. Miura et al., “The Nitrofurans, in Progress in Medicine Chemistry”; vol. 5 (G.P. Ellis & G.B. West, Eds.); 1967; New York, N.Y.; Plenum; pp. 320-381.
T. Monson et al., “Evaluation of a Polymer-coated Indwelling Catheter in Prevention of Infection”, J. Urology, 111: 220-222 (1974).
I. Sakamoto et al., “Efficacy of an Antibiotic Coated Indewlling Catheter: A Preliminary Report”, J. Biomed Materials Res. 19: 1031-1041 (1985).
Z. Shah et al., “Capsular Contracture Around Silicone Implants: The role of Intraluminal Antibiotics”, Plastic and Reconstr. Surg., 69: 809-814 (1982).
R. Van Noort, “Mechanical Properties of Antibacterial Silicone Rubber for Hydrocephalus Shunts”, J. Biomed. Materials Res., 13: 623-630 (1979).
H. Mooro et al., “Prevention of Catheter Fever by the Use of Fruacin Uretheral Inserts”, J. Egypt Med. Assoc. (Egypt), 49(8): 550-553 (1966).
J. L. Nosher et al., “Antibiotic bonded Nephrostomy Catheters for Percutaneious Nephrostomies”, Cardiovasc. Interventional Radiol. 13: 102-106 (1990).
M. Rehula, Cesk. Farm. (Czechoslovakia) 39/10: 436-437 (1990).
M. Rehula, Cesk. Farm. (Czechoslovakia) 39/8: 349-352 (1990).
D. N. Rushton et al., “Implant Infections and Antibiotic-Impregnated Silicone Rubber Coating”, J. Neurol Neurosurg., Psych., 52: 223-229 (1989).
The Bard Hospital Division brochure (copyright on a date unknown pior to Nov. 19, 1989 by C. R. Bard, Inc., Murray Hill, N.J. 07974.
*Kurt K. Nielsen et al., “The Urethral Plug: A New Treatment Modality for Genuine Urinary Stress Incontinence in Women” The Journal of Urology, vol. 144, No. 5, Nov. 1990, pps. 1199-1202.
*K. K. Nielsen et al., “The Uretheral Plug II: An Alternative Treatment in Women with Genuine Urinary Stress Incontinence”, British Journal of Urology, (1993) 72, 428-432.
Continuations (1)
Number Date Country
Parent 08/413698 Mar 1995 US
Child 08/533911 US
Continuation in Parts (5)
Number Date Country
Parent 07/827936 Jan 1992 US
Child 08/285026 US
Parent 07/809281 Dec 1991 US
Child 07/827936 US
Parent 07/489462 Mar 1990 US
Child 07/809281 US
Parent 07/487422 Mar 1990 US
Child 07/489462 US
Parent 07/462832 Jan 1990 US
Child 07/487422 US